Picture of AlphaTON Capital logo

ATON AlphaTON Capital Share Price

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+4.93%
3m-6.5%
6m-42.54%
1yr-23.67%
Volume Change (%)
10d/3m+657.63%
Price vs... (%)
52w High-63.21%
50d MA-15.47%
200d MA-8.21%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-575.29%
Return on Equity-347.11%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202631st Mar 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of AlphaTON Capital EPS forecast chart

Profile Summary

AlphaTON Capital Corp., formerly Portage Biotech Inc., is a specialized digital asset treasury company. The Company is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The Company implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. It is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The Company engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.

Directors

Last Annual
March 31st, 2025
Last Interim
March 31st, 2025
Incorporated
July 5th, 2013
Public Since
October 28th, 2013
No. of Employees
3
Sector
Investment Banking & Investment Services
Industry
Financials
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
5,881,902

ATON Share Price Performance

Upcoming Events for ATON

Q2 2026 Portage Biotech Inc Earnings Release

Similar to ATON

Picture of Aether Holdings logo

Aether Holdings

us flag iconNASDAQ Capital Market

Picture of Agora Digital Holdings logo

Agora Digital Holdings

us flag iconNASDAQ Capital Market

Picture of Agriforce Growing Systems logo

Agriforce Growing Systems

us flag iconNASDAQ Capital Market

Picture of ALT5 Sigma logo

ALT5 Sigma

us flag iconNASDAQ Capital Market

Picture of AlTi Global, logo

AlTi Global,

us flag iconNASDAQ Capital Market

FAQ